Sample Collection Devices Global Market Report 2025

The sample collection devices market size has grown strongly in recent years. It will grow from $10.56 billion in 2024 to $11.15 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. This historical growth is driven by the rising prevalence of chronic diseases, frequent outbreaks of infectious diseases, increased awareness regarding early diagnosis, expansion of healthcare infrastructure, and enhanced government healthcare initiatives.

The sample collection devices market size is expected to see strong growth in the next few years. It will grow to $13.72 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. This growth forecast is supported by the rising demand for point-of-care testing, wider adoption of personalized medicine, increased investments in healthcare technology, growth of diagnostic laboratories, and a stronger emphasis on patient-centric healthcare. Key trends during the forecast period include advancements in automated collection systems, innovation in biodegradable materials, the emergence of mobile sample collection units, research in non-invasive devices, and greater integration of smart technologies within sample collection processes.

The rising number of diagnostic and screening tests is expected to drive the growth of the sample collection devices market in the coming years. Diagnostic and screening tests are medical procedures used to detect, identify, or monitor diseases or health conditions in individuals. This increase is attributed to growing healthcare awareness as more people seek early detection to prevent serious illnesses. Sample collection devices play a crucial role in these tests by ensuring accurate and reliable specimen collection, which allows for timely and precise disease diagnosis. They also enhance testing efficiency and improve patient comfort, contributing to better healthcare outcomes. For example, according to the National Health Service in the UK, the number of diagnostic tests conducted rose to 2,544,809 in 2024, up from 2,312,030 in 2023. Hence, the growth in diagnostic and screening tests is fueling the expansion of the sample collection devices market.

Leading companies in the sample collection devices market are focusing on the development of advanced products such as volumetric dried blood sampling systems, which improve sample accuracy and patient convenience while enabling remote diagnostics and providing reliable results for laboratory analysis. Volumetric dried blood sampling involves collecting a precise, fixed volume of blood that is dried on a specialized medium for later testing. For instance, in February 2025, Tasso Inc., a medical technology firm based in the US, introduced a next-generation dried blood spot collection system that combines the Tile-T20 cartridge with the Tasso Mini device. This system allows for precise, volumetrically controlled blood collection that is nearly painless and easy to use. It aims to enhance the patient experience and optimize workflows in clinical trials, remote diagnostics, and sports anti-doping tests by eliminating traditional finger sticks and improving accuracy and convenience.

In March 2024, Halma plc, a UK-based technology company, acquired Rovers Medical Devices B.V., a Netherlands-based medical technology firm specializing in sample collection devices, for $96.07 million (€85 million). Through this acquisition, Halma intends to strengthen its healthcare portfolio by advancing women’s health using Rovers Medical Devices’ innovative sample collection technologies. This move supports enhanced cervical cancer screening and aligns with the World Health Organization’s cancer prevention objectives.

Major players in the sample collection devices market are Cardinal Health Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Grifols S.A., Terumo Corporation, SD Biosensor Inc., Haemonetics Corporation, Sarstedt Aktiengesellschaft & Co., Macopharma S.A., Bio-Rad Laboratories Inc., KABE LABORTECHNIK GmbH, Trajan Scientific and Medical Pty Ltd., Owen Mumford Limited, Mitra Industries Private Limited, CML Biotech (P) Ltd., Kawasumi Laboratories Inc., Demophorius Healthcare Ltd., Ljungberg & Kögel Aktiebolag, Romed Holland B.V.

North America was the largest region in the sample collection devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sample collection devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sample collection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sample collection devices are specialized instruments designed to safely collect, store, and transport biological specimens for diagnostic, research, or forensic applications. These devices preserve the sample’s integrity and sterility from the moment of collection until analysis, ensuring precise, contamination-free sampling, which is essential for dependable test outcomes.

The primary types of sample collection devices include needles and syringes, containers, bags, chromosome harvesters, cell harvesters, medical suitcases, and others. Needles and syringes are medical tools used together to either inject fluids into or withdraw fluids from the body. These devices are employed to collect a variety of sample types, such as blood, urine, and more. Sample collection devices find applications in diagnostics and treatment, catering to end-users like hospitals, diagnostic centers, blood banks, and others.

The sample collection devices market research report is one of a series of new reports that provides sample collection devices market statistics, including the sample collection devices industry global market size, regional shares, competitors with the sample collection devices market share, detailed sample collection devices market segments, market trends, and opportunities, and any further data you may need to thrive in the sample collection devices industry. These sample collection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sample collection devices market consists of sales of swab-based collection devices, blood collection devices, urine collection devices, saliva collection devices, stool collection devices and sputum collection devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.